TriSalus Life Sciences, Inc.
TLSINASDAQHealthcareMedical Devices
As of Oct 16, 2026 close
- Market cap
- $226.77M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.20$7.95
- Volume (live)
- -
- Avg. volume (3M)
- 379.69K
TriSalus Life Sciences (TLSI) Stock Price & Financial Analysis
TriSalus Life Sciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.58 - $3.90 |
|---|---|
| 52-Week High | $7.95 |
| 52-Week Low | $2.20 |
| Open | $3.83 |
| Volume (last close) | 253.52K |
| Average Volume (3M) | 379.69K |
| Revenue (TTM) | 45.08M |
|---|---|
| Net Income (TTM) | -28.21M |
| Free Cash Flow (TTM) | -23.28M |
| EPS (TTM) | −$0.56 |
| Profit Margin | -62.59% |
| Operating Margin | -67.68% |
| Return on Equity (ROE) | -430.72% |
| Debt to Equity | 5.09 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 226.77M |
|---|---|
| Shares Outstanding | 58.30M |
| Price to Sales (P/S) | 5.03 |
| Price to Book (P/B) | 34.62 |
| EV/EBITDA | -8.94 |
| 50-Day MA | $4.83 |
|---|---|
| 200-Day MA | $4.55 |
| 1-Year Change | −22.51% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
TriSalus Life Sciences at a Glance
As of the Oct 16, 2026 close, TriSalus Life Sciences (TLSI) has a market capitalization of $226.77M. The stock trades at 5.0× sales. Over the trailing twelve months it lost $28.21M on revenue of $45.08M and burned $23.28M of free cash flow. Revenue grew 25.3% year over year.
As of its latest reported balance sheet, it holds $46.29M in cash and securities against $33.31M of debt, a net cash position of $12.98M.
TriSalus Life Sciences does not currently pay a dividend.
The share price is down 22.5% over the past year. At $3.63 (the Oct 16, 2026 close) it sits within its 52-week range of $2.20 to $7.95, below its 200-day moving average of $4.55.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $10.40, 186.5% above the Oct 16, 2026 close.
Frequently Asked Questions About TriSalus Life Sciences
What is the current stock price for TLSI?
As of the Oct 16, 2026 close, TLSI stock trades at $3.63. The 52-week range is $2.20–$7.95, with a day range of $3.58–$3.90.
What is the P/E ratio for TLSI?
The P/E ratio (Price-to-Earnings) for TLSI is shown in the Key Statistics section. This valuation metric helps compare TriSalus Life Sciences, Inc. to industry peers.
Does TLSI pay dividends?
TriSalus Life Sciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for TLSI?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for TLSI is Buy. The average 12-month price target is $10.40, a 186.5% upside from the Oct 16, 2026 close of $3.63.
What is the market cap of TLSI?
As of the Oct 16, 2026 close, TriSalus Life Sciences's market capitalization is $211.6M, classifying it as a micro-cap company. TriSalus Life Sciences operates in the Healthcare sector within the Medical Devices industry.